Pathological and radiological features of false-positive lesions on [68Ga]Ga-PSMA-11 PET/CT in primary staging of prostate cancer: a radio-pathology matching analysis

被引:0
|
作者
Li, Renjie [1 ,2 ]
Fu, Yao [3 ]
Peng, Shan [3 ]
Yang, Fengjiao [4 ]
Ai, Shuyue [4 ]
Wang, Feng [4 ]
Zhang, Shun [1 ,2 ]
Guo, Hongqian [1 ,2 ]
Qiu, Xuefeng [1 ,2 ]
机构
[1] Nanjing Univ, Med Sch, Nanjing Drum Tower Hosp, Dept Urol,Affiliated Hosp, Nanjing 210008, Peoples R China
[2] Nanjing Univ, Inst Urol, Nanjing 210008, Peoples R China
[3] Nanjing Univ, Nanjing Drum Tower Hosp, Affiliated Hosp, Dept Pathol,Med Sch, Nanjing 210008, Peoples R China
[4] Nanjing Med Univ, Nanjing Hosp 1, Dept Nucl Med, Nanjing 210029, Peoples R China
基金
中国国家自然科学基金;
关键词
Ga-68]Ga-PSMA-11 PET/CT; Pathological feature; False-positive; True-negative; True-positive; MULTIPARAMETRIC MRI; EMISSION-TOMOGRAPHY; GA-68-PSMA PET/CT; PI-RADS; DIAGNOSIS; ACCURACY;
D O I
10.1007/s00259-025-07148-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose The aim of this study was to investigate the radiological and pathological characteristics of false-positive lesions on [Ga-68]Ga-PSMA-11 PET/CT during the primary staging of prostate cancer. Methods This study retrospectively analyzed 216 prostate cancer patients who had [Ga-68]Ga-PSMA-11 PET/CT before radical prostatectomy. False-positive lesion was defined as suspicious lesion with PRIMARY score >= 3 on PET/CT but benign on whole-mount pathology. To analyze the radiological and pathological features of false-positive lesions, no-uptake areas on PSMA PET/CT with benign pathology on the whole-mount specimen were randomly delineated and defined as true-negative lesions. The pathological features of false-positive and true-negative lesions were compared using Fisher's exact test. The differences of SUVmax and SUVmean between false-positive and true-positive lesions were determined and compared using the Wilcoxon matched-pairs signed-ranks test. In addition, PSMA expression in false-positive lesions was assessed by immunohistochemistry. Results A total of 36 false-positive lesions were identified on [Ga-68]Ga-PSMA-11 PET/CT: 25 (69.44%) were simple atrophy with cyst formation, 7 (19.44%) were prostatic nodular hyperplasia, 3 (8.33%) were inflammation and 1 (2.78%) was normal glands. A comparable number of 36 true-negative lesions were delineated: 21 (58.33%) were normal glands, 8 (22.22%) were simple atrophy with cyst formation, 6 (16.67%) were prostatic nodular hyperplasia, and 1 (2.78%) were inflammation. The Fisher's exact test revealed a statistically significant difference in the prevalence of simple atrophy with cyst formation between false-positive and true-negative lesions (69.44% vs. 22.22%; P < 0.001). Differences in SUVmax and SUVmean between false-positive and true-positive lesions were also statistically significant (both P < 0.001). PSMA expression in false-positive lesions was confirmed via immunohistochemistry. Conclusion This study determined that simple atrophy with cyst formation is a distinctive pathological feature of false-positive lesions on [Ga-68]Ga-PSMA-11 PET/CT. This observation is likely attributable to the elevated PSMA expression in simple atrophy with cyst formation, as confirmed by histological analysis. Additionally, false-positive lesions were found to have significantly lower SUV compared to true-positive lesions.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] The role of 68Ga-PSMA-I&T PET/CT in the pretreatment staging of primary prostate cancer
    Meyrick, Danielle P.
    Asokendaran, Marcus
    Skelly, Laura A.
    Lenzo, Nat P.
    Henderson, Andrew
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (11) : 956 - 963
  • [22] [68Ga]PSMA-11 for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer
    Clore, Jessica
    Scott, Peter J. H.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2024,
  • [23] Incremental Impact of [68 Ga]Ga-PSMA-11 PET/CT in Primary N and M Staging of Prostate Cancer Prior to Curative-Intent Surgery: a Prospective Clinical Trial in Comparison with mpMRI
    Florian Szigeti
    Gregor Schweighofer-Zwink
    Matthias Meissnitzer
    Cornelia Hauser-Kronberger
    Wolfgang Hitzl
    Thomas Kunit
    Rosemarie Forstner
    Christian Pirich
    Mohsen Beheshti
    Molecular Imaging and Biology, 2022, 24 : 50 - 59
  • [24] The clinical predictive value of radiomic features from [68Ga]Ga-PSMA-11 and [18F]F-PSMA-1007 PET in patients with prostate cancer: a preliminary comparative study
    Pizzuto, Daniele Antonio
    Guerreri, Michele
    Zamboglou, Constantinos
    Boldrini, Luca
    Gatta, Roberto
    Ruggiero, Maria R.
    De Summa, Marco
    Caldarella, Carmelo
    Annunziata, Salvatore
    CLINICAL AND TRANSLATIONAL IMAGING, 2024, 12 (06) : 629 - 638
  • [25] Incorporating the [68Ga]Ga-PSMA PET/CT PRIMARY score into the selection criteria for prostate cancer patients eligible for active surveillance
    Kabasakal, Levent
    Turkay, Rustu
    Onal, Bulent
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (05) : 1464 - 1466
  • [26] [68Ga]PSMA PET/CT Improves Initial Staging and Management Plan of Patients with High-Risk Prostate Cancer
    Hirmas, Nader
    Al-Ibraheem, Akram
    Herrmann, Ken
    Alsharif, Abedalatif
    Muhsin, Haider
    Khader, Jamal
    Al-Daghmin, Ali
    Salah, Samer
    MOLECULAR IMAGING AND BIOLOGY, 2019, 21 (03) : 574 - 581
  • [27] A single-center, multi-factor, retrospective study to improve the diagnostic accuracy of primary prostate cancer using [68Ga]Ga-PSMA-11 total-body PET/CT imaging
    Lv, Jing
    Yu, Haojun
    Yin, Hongyan
    Shi, Yimeng
    Shi, Hongcheng
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (03) : 919 - 927
  • [28] Comparison of 68Ga-PSMA-11 PET/CT with 11C-acetate PET/CT in re-staging of prostate cancer relapse
    Regula, Naresh
    Kostaras, Vasileios
    Johansson, Silvia
    Trampal, Carlos
    Lindstrom, Elin
    Lubberink, Mark
    Velikyan, Irina
    Sorensen, Jens
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [29] The role of [68Ga]Ga-PSMA PET/CT in primary staging of newly diagnosed prostate cancer: predictive value of PET-derived parameters for risk stratification through machine learning
    Jafari, Esmail
    Dadgar, Habibollah
    Zarei, Amin
    Samimi, Rezvan
    Manafi-Farid, Reyhaneh
    Divband, Ghasemali
    Nikkholgh, Babak
    Fallahi, Babak
    Amini, Hamidreza
    Ahmadzadehfar, Hojjat
    Keshavarz, Ahmad
    Assadi, Majid
    CLINICAL AND TRANSLATIONAL IMAGING, 2024, 12 (06) : 669 - 682
  • [30] 68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour
    Uprimny, Christian
    Kroiss, Alexander Stephan
    Decristoforo, Clemens
    Fritz, Josef
    von Guggenberg, Elisabeth
    Kendler, Dorota
    Scarpa, Lorenza
    di Santo, Gianpaolo
    Roig, Llanos Geraldo
    Maffey-Steffan, Johanna
    Horninger, Wolfgang
    Virgolini, Irene Johanna
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (06) : 941 - 949